Randomized study of cefepime versus ceftazidime plus amikacin in patients with solid tumors treated with high dose chemotherapy (HDC) and peripheral blood stem cell support (PBSCS) with febrile neutropenia. (Q40462342)

From Wikidata

Jump to navigation Jump to search

scientific article published on December 2006

Language	Label	Description	Also known as
English	Randomized study of cefepime versus ceftazidime plus amikacin in patients with solid tumors treated with high dose chemotherapy (HDC) and peripheral blood stem cell support (PBSCS) with febrile neutropenia.	scientific article published on December 2006

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17169762%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Randomized study of cefepime versus ceftazidime plus amikacin in patients with solid tumors treated with high dose chemotherapy (HDC) and peripheral blood stem cell support (PBSCS) with febrile neutropenia (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17169762%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17169762%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Carlos Lumbreras

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17169762%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

author name string

A Jimeno

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17169762%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

A Arcediano

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17169762%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

S Bazares

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17169762%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

M L Amador

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17169762%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

L González-Cortijo

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17169762%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

L Robles

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17169762%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

D Castellano

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17169762%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

L Paz-Ares

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17169762%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

J Hornedo

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17169762%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

H Cortés-Funes

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17169762%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

publication date

1 December 2006

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17169762%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Clinical and Translational Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17169762%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17169762%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17169762%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

889-895

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17169762%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Clinical Significance of In Vitro Synergism Between Antibiotics in Gram-Negative Infections

1 reference

https://api.crossref.org/works/10.1007%2FS12094-006-0152-3

21 January 2018

Ceftazidime compared with piperacillin and tobramycin for the empiric treatment of fever in neutropenic patients with cancer. A multicenter randomized trial. The Intercontinental Antimicrobial Study Group

1 reference

https://api.crossref.org/works/10.1007%2FS12094-006-0152-3

21 January 2018

Cefepime as empirical monotherapy in febrile patients with hematological malignancies and neutropenia: a randomized, single-center phase II trial

1 reference

https://api.crossref.org/works/10.1007%2FS12094-006-0152-3

21 January 2018

Cefepime/amikacin versus ceftazidime/amikacin as empirical therapy for febrile episodes in neutropenic patients: a comparative study. The French Cefepime Study Group.

1 reference

https://api.crossref.org/works/10.1007%2FS12094-006-0152-3

21 January 2018

Cefepime monotherapy for the empirical treatment of fever in granulocytopenic cancer patients

1 reference

https://api.crossref.org/works/10.1007%2FS12094-006-0152-3

21 January 2018

Cefepime versus imipenem-cilastatin as empirical monotherapy in 400 febrile patients with short duration neutropenia. CEMIC (Study Group of Infectious Diseases in Cancer).

1 reference

https://pubmed.ncbi.nlm.nih.gov/17169762

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination of amikacin and carbenicillin with or without cefazolin as empirical treatment of febrile neutropenic patients. The International Antimicrobial Therapy Project Group of the European Organization for Research and Treatment of Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17169762

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17169762

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Infections in neutropenic patients I: aetiology

1 reference

https://pubmed.ncbi.nlm.nih.gov/17169762

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A Comparison of Imipenem to Ceftazidime With or Without Amikacin as Empiric Therapy in Febrile Neutropenic Patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/17169762

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ceftazidime combined with a short or long course of amikacin for empirical therapy of gram-negative bacteremia in cancer patients with granulocytopenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/17169762

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Re

1 reference

https://pubmed.ncbi.nlm.nih.gov/17169762

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Infectious complications in 126 patients treated with high-dose chemotherapy and autologous peripheral blood stem cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/17169762

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and toxicity of single daily doses of amikacin and ceftriaxone versus multiple daily doses of amikacin and ceftazidime for infection in patients with cancer and granulocytopenia. The International Antimicrobial Therapy Cooperative Group of t

1 reference

https://pubmed.ncbi.nlm.nih.gov/17169762

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized study of ceftazidime versus gentamicin plus cefotaxime for infections in severe granulocytopenic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/17169762

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase II study of high-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17169762

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Outpatient therapy with oral ofloxacin for patients with low risk neutropenia and fever: a prospective, randomized clinical trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17169762

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monotherapy or aminoglycoside-containing combinations for empirical antibiotic treatment of febrile neutropenic patients: a meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17169762

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of febrile neutropenia with cefepime monotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17169762

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antibiotics and growth factors in the management of fever and neutropenia in cancer patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17169762

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sequential prophylactic oral and empiric once-daily parenteral antibiotics for neutropenia and fever after high-dose chemotherapy and autologous bone marrow support

1 reference

https://pubmed.ncbi.nlm.nih.gov/17169762

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antibiotic synergism and response in gram-negative bacteremia in granulocytopenic cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/17169762

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cefepime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17169762

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ceftazidime in combination with glycopeptide antibiotic is an effective first-line therapy for patients undergoing high-dose therapy with autologous peripheral blood stem cell support

1 reference

https://pubmed.ncbi.nlm.nih.gov/17169762

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/17169762

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of a prediction rule

1 reference

https://pubmed.ncbi.nlm.nih.gov/17169762

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised comparison of oral ofloxacin alone with combination of parenteral antibiotics in neutropenic febrile patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/17169762

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparative study of imipenem versus piperacillin plus gentamicin in the initial management of febrile neutropenic patients with haematological malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/17169762

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Open randomized study of cefepime versus piperacillin-gentamicin for treatment of febrile neutropenic cancer patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17169762

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ceftazidime and ciprofloxacin as empiric therapy in febrile neutropenic patients undergoing hematopoietic stem cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/17169762

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Empiric antimicrobial therapy of febrile neutropenic patients undergoing haematopoietic stem cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/17169762

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rifampin does not improve the efficacy of quinolone antibacterial prophylaxis in neutropenic cancer patients: results of a randomized clinical trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17169762

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12094-006-0152-3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17169762%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17169762%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40462342&oldid=2203708295"